Amplifon SpA (AMP):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Amplifon SpA (AMP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7438
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Amplifon SpA (Amplifon) is a medical device company, which provides customized hearing solutions and services. It distributes hearing aids and other audio and telephony solutions. The company also offers related services such as audiological assessment, education, counseling, customization and fitting solutions. It distributes products through independent retailers, corporate shops, franchisees, shop-in-shops and corners. Amplifon promotes clinical research and offers information on the advances and developments in the fields of audiology and otology through its Center for Research and Studies. The company operates in Europe, the Middle East, Africa; the Americas; and Asia Pacific regions. Amplifon is headquartered in Milano, Italy.

Amplifon SpA (AMP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Amplifon SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Amplifon SpA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Amplifon SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Amplifon SpA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Amplifon SpA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Amplifon SpA, Medical Equipment, Deal Details 10
Asset Purchase 10
Amplifon Acquires 38 Hearing Instrument Stores In India From GN ReSound 10
Debt Offering 11
Amplifon Completes Private Placement Of Bonds Due 2018 For US$357 Million 11
Asset Transactions 12
GN Otometrics Acquires Italian Biomedical Business from Amplifon 12
Acquisition 13
Amplifon May Acquire AudioNova International 13
Amplifon Acquires Audika Italia for USD10 Million 15
Amplifon SpA – Key Competitors 16
Amplifon SpA – Key Employees 17
Amplifon SpA – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Strategy And Business Planning 20
Mar 26, 2018: Capital Markets Day : Strategic Pillars, Growth Opportunities And Financial Targets For The 2018 – 2020 Period 20
Financial Announcements 22
Jul 26, 2018: Amplifon: The first half of 2018 confirms the strong growth trend in revenues and improvement in profitability 22
Mar 01, 2018: Amplifon: 2017 Third Year of Record Revenues and EBITDA 25
Oct 25, 2017: Amplifon: The Path Of Strong Growth And Improving Profitability Continues 28
Product News 31
May 10, 2017: The Hearing Brain – There Is A ‘Vicious-Circle’ Between Hearing Loss And Cognitive Decline: Hearing Loss Increases By Over 3 Times The Risk Of Dementia, Which In 3 Out Of 4 Is Accompanied By Hearing Loss 31
Other Significant Developments 33
Jul 05, 2017: Partnership Makes Hearing Aids and Services More Affordable 33
Jun 19, 2017: Amplifon And Cochlear Italia Enter Into An Exclusive Partnership Agreement For The Italian Market 34
Jun 05, 2017: Amplifon Selects Carat As Media Partner For Europe 35
Mar 21, 2017: Amplifon selects LOLA MullenLowe as international agency of record 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Amplifon SpA, Medical Equipment, Key Facts, 2017 2
Amplifon SpA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Amplifon SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Amplifon SpA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Amplifon SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Amplifon SpA, Deals By Market, 2012 to YTD 2018 8
Amplifon SpA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Amplifon Acquires 38 Hearing Instrument Stores In India From GN ReSound 10
Amplifon Completes Private Placement Of Bonds Due 2018 For US$357 Million 11
GN Otometrics Acquires Italian Biomedical Business from Amplifon 12
Amplifon May Acquire AudioNova International 13
Amplifon Acquires Audika Italia for USD10 Million 15
Amplifon SpA, Key Competitors 16
Amplifon SpA, Key Employees 17
Amplifon SpA, Subsidiaries 18

List of Figures
Amplifon SpA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Amplifon SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Amplifon SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Amplifon SpA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Amplifon SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Amplifon SpA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Amplifon SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Amplifon SpA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Amplifon SpA (AMP):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Warren Resources Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Warren Resources Inc (Warren Resources) is an oil and gas company that acquires, explores and develops crude oil and natural gas in the US. The company priovides exploration and development of waterflood oil recovery properties in the Wilmington Field in the Los Angeles Basin of California. …
  • Bonterra Energy Corp (BNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Bonterra Energy Corp (Bonterra) is an oil and gas company. It acquires and develops producing or undeveloped oil and gas properties. It produces crude oil, natural gas and natural gas liquids. The company principally operates in the provinces of Alberta, British Columbia and Saskatchewan in …
  • Syros Pharmaceuticals Inc (SYRS):製薬・医療:M&Aディール及び事業提携情報
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company’s pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that is used t …
  • Samsung Medison Co Ltd:企業の戦略的SWOT分析
    Samsung Medison Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Orange Polska S.A.:戦略・SWOT・企業財務分析
    Orange Polska S.A. - Strategy, SWOT and Corporate Finance Report Summary Orange Polska S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pharma Mar SA (PHM):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharma Mar SA (Pharma Mar) is a biopharmaceutical company that discovers, develops and markets marine-derived drugs to treat cancer. The company’s marketed product Yondelis (trabectedin), a novel, multimodal, synthetically produced antitumor agent, is indicated for the treatment of advanced …
  • Vectrus Inc (VEC):企業の財務・戦略的SWOT分析
    Vectrus Inc (VEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • La Plata Electric Association, Inc.:発電所・企業SWOT分析
    La Plata Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Topdanmark AS (TOP):企業の財務・戦略的SWOT分析
    Topdanmark AS (TOP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Shangri-La Asia Ltd:企業の戦略・SWOT・財務情報
    Shangri-La Asia Ltd - Strategy, SWOT and Corporate Finance Report Summary Shangri-La Asia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Banco Santander-Chile:企業の戦略・SWOT・財務分析
    Banco Santander-Chile - Strategy, SWOT and Corporate Finance Report Summary Banco Santander-Chile - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Gordon Ramsay Holdings Limited:企業の戦略・SWOT・財務情報
    Gordon Ramsay Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Gordon Ramsay Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Tempo Beverages Ltd.:企業の戦略・SWOT・財務分析
    Tempo Beverages Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tempo Beverages Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kernel Holding SA:企業の戦略・SWOT・財務情報
    Kernel Holding SA - Strategy, SWOT and Corporate Finance Report Summary Kernel Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • FuelCell Energy Inc (FCEL)-エネルギー分野:企業M&A・提携分析
    Summary FuelCell Energy, Inc. (FuelCell Energy) is an integrated fuel cell company that designs, manufactures, installs, operates, and services stationary fuel cell power plants for distributed power generation. It offers proprietary fuel cell products based on Direct FuelCell (DFC) carbonate fuel c …
  • Unibail-Rodamco-Westfield Se
    Unibail-Rodamco-Westfield Se - Strategy, SWOT and Corporate Finance Report Summary Unibail-Rodamco-Westfield Se - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Tom N Toms Holdings Co., Ltd.:企業の戦略・SWOT・財務情報
    Tom N Toms Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tom N Toms Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Unchained Labs-製薬・医療分野:企業M&A・提携分析
    Summary Unchained Labs is a life science tools company which offers protein stability assessment products for biologics. Its product portfolio includes UNcle (biologics stability platform), HUNK (aggregation predictor), pUNk (protein sizing system), GRUNT (automated formulation preparation system), …
  • CIMB Group Holdings Bhd:企業の戦略・SWOT・財務情報
    CIMB Group Holdings Bhd - Strategy, SWOT and Corporate Finance Report Summary CIMB Group Holdings Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Clover Corp Ltd (CLV):企業の財務・戦略的SWOT分析
    Summary Clover Corporation Limited (Clover), is a developer of science-based bioactives. The company offers products such as DHA oils, DHA powders and microencapsulation. It delivers bioactive ingredients through encapsulation. Clover’s refined tuna oil is used in various formulations, supplements, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆